Exact Mass: 718.309

Exact Mass Matches: 718.309

Found 18 metabolites which its exact mass value is equals to given mass value 718.309, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Verteporfin

3-[(23S,24R)-14-ethenyl-5-(3-methoxy-3-oxopropyl)-22,23-bis(methoxycarbonyl)-4,10,15,24-tetramethyl-25,26,27,28-tetraazahexacyclo[16.6.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶.0¹⁹,²⁴]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid

C41H42N4O8 (718.3002)


Verteporfin, otherwise known as benzoporphyrin derivative (trade name Visudyne), is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to the endothelium and blockage of the vessels.

   

Visudyne

3-[14-ethenyl-5-(3-methoxy-3-oxopropyl)-22,23-bis(methoxycarbonyl)-4,10,15,24-tetramethyl-25,26,27,28-tetraazahexacyclo[16.6.1.1^{3,6}.1^{8,11}.1^{13,16}.0^{19,24}]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid

C41H42N4O8 (718.3002)


   

Cratoxyarborequinone A

Cratoxyarborequinone A

C44H46O9 (718.3142)


   

jashemsloside C

jashemsloside C

C33H50O17 (718.3048)


   

9-O-[6-O-(5-O-syringoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-(9R)-3,5,6,9-tetrahydroxymegastigman-7-ene|eryciboside J

9-O-[6-O-(5-O-syringoyl-beta-D-apiofuranosyl)-beta-D-glucopyranosyl]-(9R)-3,5,6,9-tetrahydroxymegastigman-7-ene|eryciboside J

C33H50O17 (718.3048)


   

Verteporfin

Verteporfin (Visudyne)

C41H42N4O8 (718.3002)


   

Visudyne

Visudyne

C41H42N4O8 (718.3002)


D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents

   

Verteporfin D isomer

Verteporfin D isomer

C41H42N4O8 (718.3002)


C1420 - Photosensitizing Agent

   

(2S,2(1)R)-8-ethenyl-2(1),2(2)-bis(methoxycarbonyl)-17-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13-propanoic acid

(2S,2(1)R)-8-ethenyl-2(1),2(2)-bis(methoxycarbonyl)-17-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-13-propanoic acid

C41H42N4O8 (718.3002)


   

Bpd-MA-A1

Bpd-MA-A1

C41H42N4O8 (718.3002)


   

(2S,2(1)R)-8-ethenyl-2(1),2(2)-bis(methoxycarbonyl)-13-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-17-propanoic acid

(2S,2(1)R)-8-ethenyl-2(1),2(2)-bis(methoxycarbonyl)-13-(3-methoxy-3-oxopropyl)-2,7,12,18-tetramethyl-2,2(1)-dihydrobenzo[b]porphyrin-17-propanoic acid

C41H42N4O8 (718.3002)


   

N-(2-aminophenyl)-4-[[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide

N-(2-aminophenyl)-4-[[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzamide

C38H41F3N6O5 (718.309)


   

Verteporfin(200MG)

Verteporfin(200MG)

C41H42N4O8 (718.3002)


   

LPIM1 15:1

LPIM1 15:1

C30H55O17P (718.3177)


   

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6r)-2,6-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octa-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6r)-2,6-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octa-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C33H50O17 (718.3048)


   

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6s)-2,6-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octa-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

methyl (1s,4as,6s,7r,7as)-6-{[(2e,6s)-2,6-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octa-2,7-dienoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C33H50O17 (718.3048)


   

2-[1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3-methylbutyl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

2-[1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3-methylbutyl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

C44H46O9 (718.3142)


   

2-[(1r)-1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3-methylbutyl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

2-[(1r)-1-(3-benzoyl-6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-2,4-dihydroxyphenyl)-3-methylbutyl]-1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione

C44H46O9 (718.3142)